MoneyWorks4Me

Glenmark Pharmaceuticals submits media release

07 Jan 2020 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg’. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1751.85
Dr. Reddys Labs. 1178.10
Cipla 1296.00
Lupin 1952.60
Zydus Lifesciences 1117.75
View more..